|
News For CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES From The Last 14 Days Check below for free stories on CAT;IQNT;GRMN;JCP;JNJ;KRC;NKTR;STRA;VRTX;VNO;BMY;PBR;HES the last two weeks. |
|
|
| May 8, 2013 |
| 11:43 EDT |  | CAT | Caterpillar sees some 'encouraging signs' in China business
Subscribe for More Information |
|
| 10:33 EDT |  | BMY | Bristol-Myers, Pfizer announced results from ARISTOTLE trial subanalysis Bristol-Myers (BMY) and Pfizer (PFE) announced yesterday that results from a prespecified subanalysis of the ARISTOTLE trial were published in Circulation, the peer-reviewed journal of the American Heart Association. Results from the subanalysis showed that the reductions in stroke or systemic embolism, number of major bleeding events and mortality demonstrated with Eliquis compared to warfarin in the ARISTOTLE trial were consistent across subgroups defined based on levels of International Normalized Ratio control in patients with nonvalvular atrial fibrillation. This story corrects a headline from yesterday. |
|
| 10:00 EDT |  | JCP | On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: Ametek (AME) upgraded to Buy from Neutral at Citigroup... IAMGOLD (IAG) upgraded to Buy from Hold at Canaccord... Lowe's (LOW) upgraded to Buy from Neutral at ISI Group... lululemon (LULU) upgraded to Buy from Neutral at Sterne Agee... Myriad Genetics (MYGN) upgraded to Buy from Neutral at Mizuho... Orion Marine (ORN) upgraded to Outperform from Market Perform at FBR Capital... Trex Company (TREX) upgraded to Buy from Hold at BB&T... U.S. Auto Parts (PRTS) upgraded to Buy from Neutral at Roth Capital... Electronic Arts (EA) upgraded to Neutral from Sell at Monness Crespi... Electro Scientific (ESIO) upgraded to Buy from Hold at Noble Financial... Darling (DAR) upgraded to Buy from Hold at Maxim... J.C. Penney (JCP) upgraded to Hold from Sell at Maxim... Louisiana-Pacific (LPX) upgraded to Neutral from Underperform at DA Davidson... Grupo Televisa (TV) upgraded to Overweight from Equal Weight at Morgan Stanley... Marathon Oil (MRO) upgraded to Outperform from Neutral at Macquarie... Sibanye Gold (SBGL) upgraded to Overweight from Neutral at JPMorgan... Carrols Restaurant (TAST) upgraded to Strong Buy from Outperform at Raymond James. |
|
| 09:25 EDT |  | JCP | J.C. Penney could generate signficant profits by 2016, says Buckingham
Subscribe for More Information |
|
| 08:57 EDT |  | JCP | Follow-up: J.C. Penney upgraded to Hold from Sell at Maxim
Subscribe for More Information |
|
| 08:45 EDT |  | JCP | J.C. Penney upgraded to Hold from Sell at Maxim
Subscribe for More Information |
|
| 08:33 EDT |  | JCP | J.C. Penney estimates lowered on Q1 sales decline at Morgan Stanley
Subscribe for More Information |
|
| 07:38 EDT |  | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 7, 2013 |
| 18:58 EDT |  | CAT | Caterpillar set to resume talks with union, WSJ says
Subscribe for More Information |
|
| 16:12 EDT |  | JCP | J.C. Penney shares up 40c to $16.80 following Q1 sales results
|
| |
| 16:11 EDT |  | JCP | J.C. Penney sees Q1 revenue $2.635B, consensus $2.74B
Subscribe for More Information |
|
| 16:10 EDT |  | JCP | J.C. Penney sees Q1 SSS down 16.6%
Subscribe for More Information |
|
| 16:08 EDT |  | JCP | J.C. Penney reports Q1 revenue $2.635B, consensus $2.74B
Subscribe for More Information |
|
| 15:23 EDT |  | JCP, HES | Sohn conference presentations likely to move stocks again The Sohn Investment Conference is set to take place tomorrow in New York City. Among the notable presenters are David Einhorn, Bill Ackman, and Jeff Gundlach, each of whom presented a year ago. LOOKING BACK: A year ago, both Gundlach and Einhorn addressed Apple (AAPL) in their presentations, taking opposite sides of the trade. Gundlach said that he was short Apple, while Einhorn said he was long the stock. Gundlach reiterated his short position on Apple in a number of interviews during the year, including a prediction in January that Apple shares would reach $425 in the first quarter, a level the stock closed below on March 4. On April 29, Gundlach told CNBC he was no longer short Apple. Einhorn, meanwhile, filed a suit against the company in February in an effort to get it to distribute some of its cash hoard to investors. Earlier today, Einhorn said in an earnings conference call for Greenlight Capital that he has added to his Apple long position and praised the company's plan to return more capital to holders. Apple shares are down more than 19% over the last year, though shares have rallied more than 15% from their April lows. At last year's conference, Bill Ackman discussed his long position in J.C. Penney (JCP). Ackman, a member of Penney's board, said the company was going through with its in-store makeover strategy, led by then CEO Ron Johnson. J.C. Penney shares have slipped 50% over the last year, with Johnson leaving his CEO post on April 8. OTHER POSITIONS: Over the last year, both Einhorn and Gundlach have mentioned shorting Chipotle (CMG). In October, Einhorn recommended shorting Chipotle, saying Taco Bell (YUM) was a threat to the burrito chain. At a presentation last month, Gundlach said the idea of a gourmet burrito is an oxymoron. Shares of Chipotle are down more than 3% today ahead of tomorrow's conference, though neither investor has confirmed they hold short positions in its shares. In addition to his long position in J.C. Penney, Ackman has a high-profile short position in Herbalife (HLF), which he has called "a pyramid scheme." Ackman has been in a public spat with Carl Icahn over the company in which, according to Icahn's most recent SEC filings, he holds a better than 15% stake. Herbalife shares, which lost more than 39% following Ackman's initial presentation, are up slightly better than 1.5% since Ackman's initial comments. OTHER PRESENTERS: Investors will also be watching comments in any individual stocks from famed short-seller Jim Chanos, as well as comments from Kyle Bass, who has been outspokenly bearish on Japan. Also presenting is Paul Singer of Elliott Management, which is currently in a proxy fight with Hess (HES) in an effort to add five independent directors to the company's board. Keith Meister of Corvex Management, which along with Related Fund Management has been seeking change at CommonWealth REIT (CWH), is also set to take the stage. |
|
| 10:00 EDT |  | JCP | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 08:01 EDT |  | HES | ISS, Glass Lewis support Elliott's independent nominees for Hess Corp.
Subscribe for More Information |
|
| 07:58 EDT |  | JCP | J.C. Penney $9 price target reiterated at Morgan Stanley Morgan Stanley said J.C. Penny's $1.75B debt facility secured by real estate primary shifts value to debt holders from stockholders. The analyst values J.C. Penny's real estate at approximately $12 per share but said valuation would be much lower in a distressed scenario and that ongoing losses outflows will erode the $12 value. The firm reiterates its Underweight rating and $9 price target and believes the only catalyst for shares is a a sales and operational recovery. |
|
| 07:24 EDT |  | VNO | Vornado appoints Chief Administrative Officer, CFO
Subscribe for More Information |
|
| 06:15 EDT |  | JCP | J.C. Penney initiated with an Underperform at Wells Fargo
Subscribe for More Information |
|
|
|
|
|